Apellis Pharmaceuticals Aktie
23,17
EUR
-0,47
EUR
-1,97
%
25,05
USD
-0,27
USD
-1,08
%
Werbung
Apellis Pharmaceuticals Aktie Analyse
01.08.19 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
30.07.18 | Apellis Pharmaceuticals Buy | B. Riley FBR | |
24.05.18 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
12.04.18 | Apellis Pharmaceuticals Neutral | B. Riley FBR, Inc. | |
08.02.18 | Apellis Pharmaceuticals Buy | B. Riley FBR, Inc. |
Werbung
Werbung